Term: Quality Indicator (QI) - IMPRxOVE Program
Last Updated: 2015-01-29
Markers that have been developed by Care Management Technologies (CMT) to reflect the presence or absence of potential shortcomings in the provision of care. These indicators are not intended to identify definitive problems in the quality of healthcare provision, but rather are intended to serve as prompts for healthcare providers to conduct further investigation / exploration into the care that triggered the QI.
For the Manitoba IMPRxOVE Program, discussed in Chateau et al. (2015), the Quality Indicators (QI) were all related to potentially inappropriate prescribing patterns.
Table 2.1 - Select Quality Indicators Included in the Manitoba IMPRxOVE Program Evaluation, 2011-2013
for a list of the 15 QIs used in Chateau et al. (2015).
- see Chapter 3: The Manitoba IMPRxOVE Program Quality Indicator Triggers Data for more information about the quality indicators and outcomes reported in Chateau et al. (2015).
- Anti-Insomnia Agent
- Care Management Technologies (CMT)
- Comprehensive NeuroScience ™ of Canada (CNSC)
- Control Group
- Educational Mailing Package
- Educational Mailing Package Rate
- Intervention Group
- Manitoba IMPRxOVE Program
- Manitoba IMPRxOVE Program Data
- Manitoba IMPRxOVE Program Evaluation Data
- Quality Indicator Trigger Rates (QI Trigger Rates)
- Selective Serotonin Reuptake Inhibitor (SSRI)
- Chateau D, Enns M, Ekuma O, Koseva I, McDougall C, Kulbaba C, Allegro E. Evaluation of the Manitoba IMPRxOVE Program. Winnipeg, MB: Manitoba Centre for Health Policy, 2015. [Report] [Summary] (View)
Manitoba Centre for Health Policy
Community Health Sciences, Max Rady College of Medicine,
Rady Faculty of Health Sciences,
Room 408-727 McDermot Ave.
University of Manitoba
Winnipeg, MB R3E 3P5 Canada